117 related articles for article (PubMed ID: 8832608)
21. Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine.
Abelson HT; Fosburg MT; Beardsley GP; Goorin AM; Gorka C; Link M; Link D
J Clin Oncol; 1983 Mar; 1(3):208-16. PubMed ID: 6607976
[TBL] [Abstract][Full Text] [Related]
22. Neutrophil infiltration and oxidative stress may play a critical role in methotrexate-induced renal damage.
Kolli VK; Abraham P; Isaac B; Selvakumar D
Chemotherapy; 2009; 55(2):83-90. PubMed ID: 19145077
[TBL] [Abstract][Full Text] [Related]
23. The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides.
Pinedo HM; Zaharko DS; Bull JM; Chabner BA
Cancer Res; 1976 Dec; 36(12):4418-24. PubMed ID: 1087180
[TBL] [Abstract][Full Text] [Related]
24. [Morphofunctional correlates of the nephrotoxic action of cis-platin].
Bakhteeva VT; Vinnichenko LN; Gambarian SP; Miazina EM; Natochin IuV
Arkh Patol; 1987; 49(3):48-54. PubMed ID: 3593006
[TBL] [Abstract][Full Text] [Related]
25. Protective effects of vitamin C on cisplatin-induced renal damage: a light and electron microscopic study.
Tarladacalisir YT; Kanter M; Uygun M
Ren Fail; 2008; 30(1):1-8. PubMed ID: 18197536
[TBL] [Abstract][Full Text] [Related]
26. Influence of high-dose methotrexate therapy (HD-MTX) on glomerular and tubular kidney function.
Hempel L; Misselwitz J; Fleck C; Kentouche K; Leder C; Appenroth D; Rost M; Zintl F
Med Pediatr Oncol; 2003 Jun; 40(6):348-54. PubMed ID: 12692801
[TBL] [Abstract][Full Text] [Related]
27. Protective mechanisms of resveratrol against methotrexate-induced renal damage may involve BCRP/ABCG2.
El-Sheikh AA; Morsy MA; Al-Taher AY
Fundam Clin Pharmacol; 2016 Oct; 30(5):406-18. PubMed ID: 27213989
[TBL] [Abstract][Full Text] [Related]
28. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
Joannon P; Oviedo I; Campbell M; Tordecilla J
Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
[TBL] [Abstract][Full Text] [Related]
29. Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis.
Buckley LM; Vacek PM; Cooper SM
J Rheumatol; 1990 Sep; 17(9):1158-61. PubMed ID: 2132565
[TBL] [Abstract][Full Text] [Related]
30. Understanding and managing methotrexate nephrotoxicity.
Widemann BC; Adamson PC
Oncologist; 2006 Jun; 11(6):694-703. PubMed ID: 16794248
[TBL] [Abstract][Full Text] [Related]
31. Resistance of human bone marrow CFUC to high-dose methotrexate cytotoxicity.
Koizumi S; Yamagami M; Ueno Y; Miura M; Taniguchi N
Exp Hematol; 1980 May; 8(5):635-40. PubMed ID: 7461061
[TBL] [Abstract][Full Text] [Related]
32. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
Widemann BC; Balis FM; Kempf-Bielack B; Bielack S; Pratt CB; Ferrari S; Bacci G; Craft AW; Adamson PC
Cancer; 2004 May; 100(10):2222-32. PubMed ID: 15139068
[TBL] [Abstract][Full Text] [Related]
33. [Ultrastructural aspects of renal infiltration by polyvinylpyrrolidone. Apropos of a case].
Fonck-Cussac Y; Aublet-Cuvelier JL; Fonck J
Ann Anat Pathol (Paris); 1970; 15(4):461-70. PubMed ID: 5519203
[No Abstract] [Full Text] [Related]
34. Ultrastructural studies on renal peritubular amyloid experimentally induced in guinea pigs. I. General aspects.
Shirahama T; Cohen AS
Lab Invest; 1968 Jul; 19(1):122-31. PubMed ID: 5671349
[No Abstract] [Full Text] [Related]
35. A single center retrospective analysis of a protocol for high-dose methotrexate and leucovorin rescue administration.
Cerminara Z; Duffy A; Nishioka J; Trovato J; Gilmore S
J Oncol Pharm Pract; 2019 Jan; 25(1):76-84. PubMed ID: 28942720
[TBL] [Abstract][Full Text] [Related]
36. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
Edelman MJ; Meyers FJ; Houston J; Lauder I
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
[TBL] [Abstract][Full Text] [Related]
37. Melatonin attenuates methotrexate-induced oxidative stress and renal damage in rats.
Abraham P; Kolli VK; Rabi S
Cell Biochem Funct; 2010 Jul; 28(5):426-33. PubMed ID: 20589739
[TBL] [Abstract][Full Text] [Related]
38. High-dose methotrexate-doxycycline interaction.
Tortajada-Ituren JJ; Ordovás-Baines JP; Llopis-Salvia P; Jiménez-Torres NV
Ann Pharmacother; 1999; 33(7-8):804-8. PubMed ID: 10466909
[TBL] [Abstract][Full Text] [Related]
39. Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy.
Schwartz S; Borner K; Müller K; Martus P; Fischer L; Korfel A; Auton T; Thiel E
Oncologist; 2007 Nov; 12(11):1299-308. PubMed ID: 18055849
[TBL] [Abstract][Full Text] [Related]
40. Effect of infliximab on renal injury due to methotrexate in rat.
Kirbas A; Cure MC; Kalkan Y; Cure E; Tumkaya L; Sahin OZ; Yuce S; Kizilkaya B; Pergel A
Iran J Kidney Dis; 2015 May; 9(3):221-9. PubMed ID: 25957427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
